LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Cosmetic Treatment in Patients with Autoimmune Connective Tissue Diseases. Part I. Best Practices for Patients with Morphea/Systemic Sclerosis.

Photo from wikipedia

UNSTRUCTURED ABSTRACT Morphea and systemic sclerosis are inflammatory, sclerosing disorders. Morphea primarily affects the dermis and subcutaneous fat, while systemic sclerosis typically involves the skin and internal organs. Functional impairment… Click to show full abstract

UNSTRUCTURED ABSTRACT Morphea and systemic sclerosis are inflammatory, sclerosing disorders. Morphea primarily affects the dermis and subcutaneous fat, while systemic sclerosis typically involves the skin and internal organs. Functional impairment and cosmetic disfigurement are common in both diseases. Treatment options to mitigate disease progression remain limited.1,2 Both functional impairment and cosmetic deficits negatively impact quality of life and psychological well-being in this patient population.

Keywords: sclerosis; treatment patients; morphea systemic; systemic sclerosis; cosmetic treatment

Journal Title: Journal of the American Academy of Dermatology
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.